Shareholding19 Jun 2026, 03:14 pm
Parmax Pharma: Abhay Shah Acquires 2.76% Stake via Off-Market Deal
AI Summary
Abhay Chinubhai Shah (PAC 8) acquired 2,49,394 equity shares, representing 2.76% of the total share capital, in Parmax Pharma Ltd through an off-market transaction on June 18, 2026. The acquisition was made from Pradeep Gosalia for an undisclosed price per share. Following this transaction, the total shareholding of acquirers and Persons Acting in Concert (PACs) in Parmax Pharma has increased to 27.20%. This disclosure is made in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Key Highlights
- Abhay Chinubhai Shah acquired 2.76% stake in Parmax Pharma.
- Transaction was an off-market deal on June 18, 2026.
- Total PAC shareholding in Parmax Pharma now stands at 27.20%.
- Disclosure complies with SEBI (SAST) Regulations, 2011.
Price Impact
More from PARMAX